The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials

AIM: We aimed to assess the association between the use of Glucagon-like peptide-1 receptor agonists and the risk of 12 respiratory diseases in patients with type 2 diabetes, obesity, or overweight. METHOD: The PubMed (MEDLINE), EMBASE, Cochrane Library, and ClinicalTrials.gov databases were searche...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Meixin, Wang, Ruxin, Pei, Ling, Zhang, Xiaofang, Wei, Jinjing, Wen, Yun, Liu, Han, Ye, Haowen, Wang, Jinghao, Wang, Lihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369734/
https://www.ncbi.nlm.nih.gov/pubmed/37491292
http://dx.doi.org/10.1186/s13098-023-01118-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369734/
https://www.ncbi.nlm.nih.gov/pubmed/37491292
http://dx.doi.org/10.1186/s13098-023-01118-6

Ejemplares similares